C.D.C. Advisers Are Meeting About Novavax’s Covid Vaccine
July 19, 2022
(New York Times) – An influential scientific panel is discussing who should receive a newly authorized Covid-19 vaccine from Novavax, a Maryland pharmaceutical company that hopes its shot will appeal to Americans who have so far declined to be vaccinated. The independent experts, who advise the Centers for Disease Control and Prevention on its vaccine policies, are meeting Tuesday and are scheduled to vote on whether to endorse Novavax’s latecomer vaccine. (Read More)